cth120
Fragile X Syndrome
Connecta Therapeutics, S.L.Phase 2Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Fragile X Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Sertraline Holland Bloorview Kids Rehabilitation Hospital | Phase 2 | CCC |
F-PEB Institute for Neurodegenerative Disorders | Phase 1 | CC |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →